| The role of complement system in adipose tissue-related inflammation SI Vlaicu, A Tatomir, D Boodhoo, S Vesa, PA Mircea, H Rus Immunologic research 64, 653-664, 2016 | 98 | 2016 |
| The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis A Tatomir, A Talpos-Caia, F Anselmo, AM Kruszewski, D Boodhoo, V Rus, ... Immunologic research 65, 1103-1109, 2017 | 74 | 2017 |
| The role of complement activation in atherogenesis: the first 40 years SI Vlaicu, A Tatomir, V Rus, AP Mekala, PA Mircea, F Niculescu, H Rus Immunologic research 64, 1-13, 2016 | 54 | 2016 |
| SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis D Hewes, A Tatomir, AM Kruszewski, G Rao, CA Tegla, J Ciriello, ... Experimental and Molecular Pathology 102 (2), 191-197, 2017 | 34 | 2017 |
| Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis J Ciriello, A Tatomir, D Hewes, D Boodhoo, F Anselmo, V Rus, H Rus Experimental and molecular pathology 105 (2), 175-180, 2018 | 24 | 2018 |
| RGC-32 is expressed in the human atherosclerotic arterial wall: role in C5b-9-induced cell proliferation and migration SI Vlaicu, A Tatomir, D Boodhoo, T Ito, M Fosbrink, C Cudrici, AP Mekala, ... Experimental and Molecular Pathology 101 (2), 221-230, 2016 | 22 | 2016 |
| RGC-32 promotes Th17 cell differentiation and enhances experimental autoimmune encephalomyelitis V Rus, V Nguyen, A Tatomir, JR Lees, AP Mekala, D Boodhoo, CA Tegla, ... The Journal of Immunology 198 (10), 3869-3877, 2017 | 20 | 2017 |
| RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis AM Kruszewski, G Rao, A Tatomir, D Hewes, CA Tegla, CD Cudrici, ... Experimental and molecular pathology 99 (3), 498-505, 2015 | 20 | 2015 |
| Role of C5b-9 and RGC-32 in Cancer SI Vlaicu, A Tatomir, V Rus, H Rus Frontiers in immunology 10, 1054, 2019 | 19 | 2019 |
| RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis A Tatomir, CA Tegla, A Martin, D Boodhoo, V Nguyen, AJ Sugarman, ... Immunologic research 66, 445-461, 2018 | 16 | 2018 |
| RGC-32 and diseases: the first 20 years SI Vlaicu, A Tatomir, F Anselmo, D Boodhoo, R Chira, V Rus, H Rus Immunologic Research 67, 267-279, 2019 | 14 | 2019 |
| Histone deacetylase SIRT1 mediates C5b-9-induced cell cycle in oligodendrocytes A Tatomir, G Rao, D Boodhoo, SI Vlaicu, A Beltrand, F Anselmo, V Rus, ... Frontiers in Immunology 11, 619, 2020 | 11 | 2020 |
| Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis WH Hoffman, CD Cudrici, D Boodhoo, A Tatomir, V Rus, H Rus Experimental and molecular pathology 108, 97-104, 2019 | 6 | 2019 |
| Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference? WH Hoffman, CM Artlett, D Boodhoo, MGF Gilliland, L Ortiz, D Mulder, ... Experimental and Molecular Pathology 102 (3), 505-514, 2017 | 6 | 2017 |
| COVID, complement, and the brain SI Vlaicu, A Tatomir, J Cuevas, V Rus, H Rus Frontiers in Immunology 14, 1216457, 2023 | 5 | 2023 |
| RGC-32 regulates generation of reactive astrocytes in experimental autoimmune encephalomyelitis A Tatomir, A Beltrand, V Nguyen, D Boodhoo, A Mekala, C Cudrici, ... Frontiers in Immunology 11, 608294, 2021 | 5 | 2021 |
| JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response F Anselmo, A Tatomir, D Boodhoo, AP Mekala, V Nguyen, V Rus, H Rus Clinical Immunology 210, 108297, 2020 | 5 | 2020 |
| RGC-32′ dual role in smooth muscle cells and atherogenesis SI Vlaicu, A Tatomir, M Fosbrink, V Nguyen, D Boodhoo, C Cudrici, ... Clinical Immunology 238, 109020, 2022 | 4 | 2022 |
| Role of RGC-32 in multiple sclerosis and neuroinflammation–few answers and many questions A Tatomir, J Cuevas, TC Badea, DF Muresanu, V Rus, H Rus Frontiers in immunology 13, 979414, 2022 | 3 | 2022 |
| Response gene to complement-32 promotes kidney damage in immune complex–mediated glomerulonephritis A Talpos-Caia 2018 ACR/ARHP Annual Meeting, 2018 | 2 | 2018 |
